119-1843

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Last action was on 3-5-2025

Bill is currently in: House
Path to Law
House Senate President

Current status is Referred to the House Committee on Energy and Commerce.

No users have voted for/against support on this bill yet. Be the first!